Bizarre Patents
A helium-filled sun shade for protecting individuals engaged in outdoor activities.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20130122101 | ABUSE RESISTANT DRUG FORMULATION A pharmaceutical composition may include a coated particulate which may include at least one active pharmaceutical ingredient, particularly one susceptible to abuse by an individual. The coated particles may include a fat/wax and have improved controlled release and/or ... | 05/16/2013 |
| 20130115298 | EXTENDED RELEASE COMPOSITIONS COMPRISING AS ACTIVE COMPOUND VENLAFAXINE HYDROCHLORIDE The present invention relates to an extended release composition comprising as active compound Venlafaxine Hydrochloride, in which Venlafaxine Hydrochloride is coated on a non pareil inert core, which coated core is then coated with polymeric layer which enables the con... | 05/09/2013 |
| 20130115286 | ORAL ADMINISTRATION FORMS FOR CONTROLLED RELEASE OF RIFAMPICIN FOR THE TREATMENT OF BACTERIAL INFECTIONS AND INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT Oral administration forms are described for the controlled release of an antibiotic selected from the group consisting of rifampicin, rifabutin, rifapentine, rifalazil and mixtures thereof, for treating bacterial infections of the gastrointestinal tract, in particular t... | 05/09/2013 |
| 20130108703 | Orally Disintegrating Tablet Compositions of Lamotrigine The compositions of the present invention composition comprise a therapeutically effective amount of particles comprising lamotrigine, in combination with granules comprising a disintegrant, and a sugar alcohol and/or a saccharide. These compositions are useful in treat... | 05/02/2013 |
| 20130084332 | TASTE MASKED PHARMACEUTICAL COMPOSITION This application relates to taste masked multi-layered particles an inert core, one or more coating layer(s) comprising a pharmaceutically active ingredient and a binder, an intermediate coating layer (seal coating) free from a low molecular weight water-soluble ionic c... | 04/04/2013 |
| 20130084340 | Compositions and Methods of Making Sustained Release Liquid Formulations The present invention includes compositions and methods for the controlled release of active agents in a shelf-stable liquid formulation by blending one or more controlled release microbeads comprising one or more active agents, preparing a dense, thixotropic solution h... | 04/04/2013 |
| 20130071481 | COATED PARTICLE AND METHOD FOR PRODUCING COATED PARTICLE The present invention relates to a coating particle containing a nuclear particle covered with a coating layer, and in the coating particle, the coating layer is a layer containing hydroxyalkyl cellulose and a binder.... | 03/21/2013 |
| 20130059010 | ALCOHOL-RESISTANT ORAL PHARMACEUTICAL FORM A sustained release oral pharmaceutical form suitable for single daily dose administration has a neutral microgranule coated with a mounting layer of active ingredient and pharmaceutically acceptable binder; and a coating layer of a hydrophobic coating polymer of a non-... | 03/07/2013 |
| 20130052269 | FORMULATIONS FOR ORAL DELIVERY OF ADSORBENTS IN THE GUT The invention relates to a formulation for the delayed and controlled delivery of an adsorbent into the lower intestine of mammals. The formulation includes a carrageenan and an adsorbent, such as activated charcoal. The invention further relates to uses of this formula... | 02/28/2013 |
| 20130052264 | CONTROLLED-RELEASE PHARMACEUTICAL COMPOSITION INCLUDING TAMSULOSIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND ORAL FORMULATION INCLUDING THE SAME A controlled-release pharmaceutical composition including first and second groups of microparticles, each of the microparticles including a core including tamsulosin or pharmaceutically acceptable salts thereof, a controlled-release polymer coating layer formed on the c... | 02/28/2013 |
| 20130022684 | ORAL PHARMACEUTICAL COMPOSITION COMPRISING FENOFIBRIC ACID AND AN ALKALIFYING AGENT An oral pharmaceutical composition of the present invention comprising fenofibric acid or a pharmaceutically acceptable salt thereof, and 0.22 to 1 part by weight of an alkalifying agent based on 1 part by weight of fenofibric acid has improved bioavailability and a min... | 01/24/2013 |
| 20130022683 | METHOD FOR IMPROVING DISSOLUTION OF ANTICOAGULANT AGENT It is desired to provide a pharmaceutical composition containing a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, or a solvate thereof, which exhibits an inhibitory effect on activated blood coagulation factor X, and is useful as an a... | 01/24/2013 |
| 20130017255 | Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent Pharmaceutical compositions and dosage forms comprising an adsorbent, and an adverse agent, such as an opioid antagonist. In one embodiment, at least a portion of the adverse agent is on the surface or within the micropore structure of an adsorbent material. The pharmac... | 01/17/2013 |
| 20130011474 | MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE The present invention provides immediate release and modified release oral dosage forms. Specifically, the invention provides modified and immediate release pharmaceutical dosage forms containing memantine that exhibit an enhanced release profile and provide reliable ab... | 01/10/2013 |
| 20130004563 | MULTIPARTICULATE S-ADENOSYLMETHIONINE COMPOSITIONS AND RELATED METHODS Multiparticulate compositions having S-adenosylmethionine an active ingredient are disclosed. The multiparticulates have spheroidal core comprising S-adenosylmethionine, microcrystalline cellulose, and hydroxypropyl methylcellulose; a sub-coat comprising hydroxypropyl m... | 01/03/2013 |
| 20130004651 | SUSTAINED DRUG RELEASE FROM BODY IMPLANTS USING NANOPARTICLE-EMBEDDED POLYMERIC COATING MATERIALS The present invention relates to the preparation of therapeutic compositions including drug-containing nanoparticles for coating a body implant to provide for drug delivery in a locally applied and extended release manner and their methods of use to treat physiological ... | 01/03/2013 |
| 20120328697 | Controlled Release Solid Dose Forms The present invention is directed to a solid dose form comprising a film coating composition encapsulating a core, wherein: (i) the core comprises an active ingredient comprising at least one of a pharmaceutical, veterinary, or nutraceutical active ingredient; (ii) the ... | 12/27/2012 |
| 20120321712 | Pharmaceutical Composition The invention relates to pharmaceutical compositions containing rosuvastatin calcium of formula (I) and processes for their manufacture. ... | 12/20/2012 |
| 20120321708 | SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to releas... | 12/20/2012 |
| 20120321702 | PHARMACEUTICAL COMPOSITION OF LANSOPRAZOLE The invention refers to an oral solid pharmaceutical composition comprising a mixture of: (a) pellets comprising lansoprazole or a pharmaceutically acceptable salt thereof being free of alkaline-reacting compounds and (b) pellets comprising lansoprazole or a pharmaceuti... | 12/20/2012 |
| 20120315336 | INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS Described are injectable formulations of particulate olanzapine that produce a prolonged duration of action upon administration, and methods of making and using such formulations. The injectable formulations comprise particulate olanzapine.... | 12/13/2012 |
| 20120315326 | MULTIPARTICULATE L-CARNITINE COMPOSITIONS AND RELATED METHODS Enteric coated multiparticulate compositions that use a L-carnitine compound an active ingredient are disclosed. The multiparticulates have spheroidal core comprising a L-carnitine, microcrystalline cellulose, and hydroxypropyl methylcellulose; a sub-coat comprising hyd... | 12/13/2012 |
| 20120315337 | MULTIPARTICULATE 5-HTP COMPOSITIONS AND RELATED METHODS Enteric coated multiparticulate compositions that use 5-HTP as an active ingredient are disclosed. The multiparticulates have a spheroidal core comprising 5-HTP, microcrystalline cellulose, and hydroxypropyl methylcellulose; a sub-coat comprising hydroxypropyl methylcel... | 12/13/2012 |
| 20120308662 | PARTICULATE PREPARATION AND METHOD FOR PRODUCING THE SAME The present invention aims to provide a particulate formulation with an effectively controlled dissolution characteristic of a drug even if the average particle diameter is small. The present invention provides a particulate formulation containing drug particles and a f... | 12/06/2012 |
| 20120301542 | EXTENDED RELEASE FORMULATIONS OF RASAGILINE AND USES THEREOF The present invention provides various pharmaceutical compositions, in particular for oral administration, formulated for extended release of active compounds useful in the treatment of neurodegenerative diseases, in particular Parkinson's disease, and injuries to the n... | 11/29/2012 |
| 20120276017 | Methods and Compositions for Treatment of Attention Deficit Disorder Therapeutic compositions and methods for treatment of attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) include dosage forms that deliver a therapeutic amount of active drug in a delayed and controlled release formulation. The dosage fo... | 11/01/2012 |
| 20120258177 | MICROCAPSULES COMPRISING BENZOYL PEROXIDE AND TOPICAL COMPOSITIONS COMPRISING THEM The present invention provides microcapsules comprising benzoyl peroxide and topical compositions comprising them, optionally along with other active ingredients, particularly for the treatment of acne.... | 10/11/2012 |
| 20120251623 | METHOD OF ADMINISTERING AN ACTIVE INGREDIENT USING A CHEWABLE ORAL DOSAGE FROM COMPRISING TEXTURE MASKED PARTICLES In one aspect, the present invention features a method of administering an active ingredient, said method comprising chewing an oral dosage form comprising a texture masked particle, said texture masked particle comprising a) a core containing an active ingredient; b) a... | 10/04/2012 |
| 20120231085 | CONTROLLED RELEASE COMPOSITIONS OF GAMMA-HYDROXYBUTYRATE The present invention is directed to oral pulse-release pharmaceutical dosage form containing an immediate release component of gamma-hydroxybutyric acid, and one or more delayed/controlled release components of gamma-hydroxybutyric acid.... | 09/13/2012 |
| 20120231084 | GALENIC FORM SUITABLE FOR ABSORBING, IN A SPECIFIC MANNER, THE UNDESIRABLE MOLECULES IN THE DIGESTIVE TRACT The present invention relates to a galenic form comprising particles capable of specifically adsorbing the undesirable molecules present in the digestive tract, to the method for preparing same and to the use thereof in particular for producing a medicine intended for p... | 09/13/2012 |
| 20120231083 | SUSTAINED RELEASE CANNABINOID MEDICAMENTS The present invention provides a medicament which results in delivery of a therapeutic level of one or more cannabinoids during a clinically relevant therapeutic window. The therapeutic window is a longer window than provided by an immediate release medicament such as M... | 09/13/2012 |
| 20120225126 | SOLID STATE SYNTHESIS METHOD OF SILVER NANOPARTICLES, AND SILVER NANOPARTICLES SYNTHESIZED THEREBY Disclosed are a solid state synthesis method of silver nanoparticles, and silver nanoparticles synthesized thereby. The method includes mixing a silver salt and a water soluble polymer acting as both a reducing agent and a protecting agent to produce a solid mixture, an... | 09/06/2012 |
| 20120225122 | Abuse-Resistant Formulations This disclosure relates to a sustained-release oral dosage form for once-a-day administration comprising a matrix containing a viscosity modifier and coated granules containing hydromorphone. The dosage form can have a release profile such that 16 hours following admini... | 09/06/2012 |
| 20120207843 | FLOATING MICROGRANULES A floating granule having a solid core, on which an active ingredient is supported, and a compound capable of generating a gas discharge which is constituted by an alkaline agent, characterised in that it does not comprise an acid agent that is capable of generating a g... | 08/16/2012 |
| 20120201895 | Pharmaceutical Compositions Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one sequestering polymer are all components of a single unit, and wherein the seal coat... | 08/09/2012 |
| 20120201889 | MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE The present invention provides immediate release and modified release oral dosage forms. Specifically, the invention provides modified and immediate release pharmaceutical dosage forms containing memantine that exhibit an enhanced release profile and provide reliable ab... | 08/09/2012 |
| 20120189703 | Enzyme Delivery Systems and Methods of Preparation and Use This invention relates to coated digestive enzyme preparations and enzyme delivery systems and pharmaceutical compositions comprising the preparations. This invention further relates to methods of preparation and use of the systems, pharmaceutical compositions and prepa... | 07/26/2012 |
| 20120171297 | THREO-DOPS CONTROLLED RELEASE FORMULATION The present invention relates to pharmaceutical formulations for the controlled delivery of threo-3-(3,4-dihydroxyphenyl)serine (threo-DOPS) and derivatives of it. Such formulations can contain an extended or slow release component that maintains therapeutic concentrati... | 07/05/2012 |
| 20120171296 | RAPIDLY DISINTEGRATING SOLID PREPARATION Provided is a solid preparation which rapidly disintegrates in the presence of saliva or a small amount of water in the oral cavity, particularly, a rapidly disintegrating solid preparation useful as an orally-disintegrating solid preparation. 07/05/2012 | |
| 20120164233 | PULSATILE RELEASE PHARMACEUTICAL FORMULATION OF DEXLANSOPRAZOLE The present invention relates to a pulsatile-release pharmaceutical formulation of dexlansoprazole composed of a single type of enteric coated pellets and the process for the preparation thereof.... | 06/28/2012 |
